Endocrine-immune interactions in human endometrium

Annals of the New York Academy of Sciences

Volumn 1034, Issue , 2004, Pages 50-63

  Kayisli, U A ^a,b   Guzeloglu Kayisli, O ^a,b   Arici, A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Cytokines; Endocrine immune interactions; Human endometrium; Reproductive hormones; Survival factors

Indexed keywords

CYTOKINE; ESTROGEN; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE; PROTEIN BCL 2; PROTEIN KINASE B; SEX HORMONE; WORTMANNIN;

ANGIOGENESIS; ANTIGEN DETECTION; APOPTOSIS; BLASTOCYST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CELL; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE SYSTEM; IMPLANTATION; INFLAMMATION; MENSTRUATION; MOLECULAR INTERACTION; PROTEIN INTERACTION; REPRODUCTION; TISSUE REGENERATION; TISSUE REPAIR;

EID: 14944371915     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1335.005     Document Type: Conference Paper

References (77)

1. CALZOARI, A. 1898. Rescherches experimentales sur un rapport probable entre la function du thymus et celle de testicules. Arch. Ital. Bi. 30: 71.
2. OKUYAMA, R. et al. 1992. Estrogen administration activates extrathymic T cell differentiation in the liver. J. Exp. Med. 175: 661-669.
3. ERLANDSSON, M.C. et al. 2001. Role of oestrogen receptors α and β in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103: 17-25.
4. STAPLES, J.E. et al. 1999. Estrogen receptor a is necessary in thymic development and estradiol-induced thymic alterations. J. Immunol. 163: 4168-4174.
5. BEATO, M. et al. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83: 851-857.
6. DEFRANCO, D.B. 2002. Navigating steroid hormone receptors through the nuclear compartment. Mol. Endocrinol. 16: 1449-1455.
7. LI-WEBER, M. & P.H. KRAMMER. 2003. Function and regulation of the CD95 (APO-1/ Fas) ligand in the immune system. Semin. Immunol. 15: 145-157.
8. LESLIE, N.R. & C.P. DOWNES. 2002. PTEN: The down side of PI3-kinase signaling. Cell. Signal. 14: 285-295.
9. PLAS, D.R., J.C. RATHMELL & C.B. THOMPSON. 2002. Homeostatic control of lymphocyte survival: potential origins and implications. Nat. Immunol. 3: 515-521.
10. SEN, R. & D. BALTIMORE. 1986. Inducibility of the immunoglobulin enhancer binding protein NFB by a post translational mechanism. Cell 47: 921-928.
11. PIERCE, J.W., M. LENARDO & D. BALTIMORE. 1988. Oligonucleotide that binds nuclear NFB acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA 85: 1482-1486.
12. NABEL, G. & D. BALTIMORE. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
13. KAYISLI, U.A., N. MAHUTTE & A. ARICI. 2002. Uterine chemokines in reproductive physiology and pathology. Am. J. Reprod. Immunol. 47: 213-221.
14. CARR, B.R. 1996. The normal menstrual cycle. In The Textbook of Reproductive Medicine. B.R. Carr & R.E. Blackwell, Eds.: 233-243. Plenum Press. New York.
15. HARADA, T. et al. 2004. Apoptosis in human endometrium and endometriosis. Hum. Reprod. Update 10: 29-38.
16. YAMASHITA, H. et al. 1999. Fas ligand, Fas antigen and Bcl-2 expression in human endometrium during the menstrual cycle. Mol. Hum. Reprod. 5: 358-364.
17. SELAM, B. et al. 2001. Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol. Reprod. 65: 979-985.
18. MAKRIGIANNAKIS, A. et al. 2001. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat. Immunol. 2: 1018-1024.
19. NAGATA, S. & P. GOLSTEIN. 1995. The Fas death factor. Science 267: 1449-1456.
20. OTSUKI, Y. 2001. Apoptosis in human endometrium: apoptotic detection methods and signaling. Med. Electron. Microsc. 34: 166-173.
21. SONG, J. et al. 2002. Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Mol. Hum. Reprod. 8: 447-455.
22. WATANABE, H. et al. 1997. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am. J. Obstet. Gynecol. 176: 360-368.
23. KONNO, R. et al. 2000. Expression of survivin and Bcl-2 in the normal human endometrium. Mol. Hum. Reprod. 6: 529-534.
24. DAIKOKU, E., Y. ITO & Y. OTSUKI. 1998. The induction of apoptosis in ovaries and uteri of bcl-2 deficient mice. Med. Electron. Microsc. 31: 68-76.
25. ROGERS, P.A. et al. 2000. Bcl-2, Fas, and caspase-3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding. Hum. Reprod. 15 (Suppl 3): 152-161.
26. TAO, X.J. et al. 1997. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. J. Clin. Endocrinol. Metab. 82: 2738-2746.
27. CHITTENDEN, T. et al. 1995. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374: 731-733.
28. TAO, X.J. et al. 1998. Elevated expression of the proapoptotic BCL-2 family member, BAK, in the human endometrium coincident with apoptosis during the secretory phase of the cycle. Fertil. Steril. 70: 338-343.
29. LI, J. et al. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 28: 1943-1947.
30. STECK, P.A. et al. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15: 356-362.
31. LI, D.M. & H. SUN. 1997. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57: 2124-2129.
32. MYERS, M.P. et al. 1998. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. USA 95: 13513-13518.
33. WENG, L., J. BROWN & C. ENG. 2001. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum. Mol. Genet. 10: 237-242.
34. NICHOLSON, K.M. & N.G. ANDERSON. 2002. The protein kinase B/Akt signaling pathway in human malignancy. Cell. Signal. 14: 381-395.
35. DAVIES, M.A. et al. 1999. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 59: 2551-2556.
36. MAYO, L.D. & D.B. DONNER. 2002. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem. Sci. 27: 462-467.
37. GUZELOGLU-KAYISLI, O. et al. 2003. Regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) expression by estradiol and progesterone in human endometrium. J. Clin. Endocrinol. Metab. 88: 5017-5026.
38. GUZELOGLU-KAYISLI, O. et al. 2004. In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol. Reprod. 71: 714-721.
39. BHARTI, A.C. & B.B. AGGARWAL. 2002. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem. Pharmacol. 64: 883-888.
40. RICHMOND, A. 2002. NF-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2: 664-674.
41. th Annual Meeting of ASRM. Fertil. Steril. 74: S136.
42. BULMER, J. & P.M. JOHNSON. 1985. Immunohistochemical characterization of the human decidual leukocytic infiltrate related to endometrial gland epithelium in early human pregnancy. Immunology 55: 33-44.
43. WOOD, G.W., X. HAUSMAN & R. CHOUDHURI. 1997. Relative role of CSF-1, MCP-1/ (JE), and RANTES in macrophages recruitment during successful pregnancy. Mol. Reprod. Dev. 46: 62-70.
44. KAYISLI, U.A. et al. 2003. Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system. J. Immunol. 171: 2305-2313.
45. LEA, R.G. & D.A. CLARK. 1991. Macrophages and migratory cells in the endometrium relevant to implantation. Bailleries Clin. Obstet. Gynecol. 5: 25-29.
46. ROTELLO, R. et al. 1992. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am. J. Pathol. 140: 449-456.
47. KOH, E.T.A. et al. 1995. Immunolocalization of Bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Hum. Reprod. 10: 1557-1562.
48. TABIBZADEH, S. 1995. Signals and molecular pathways involved in apoptosis with special emphasis on human endometrium. Hum. Reprod. 1: 303-323.
49. SUN, H. et al. 2001. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia. Am. J. Clin. Pathol. 115: 32-38.
50. MUTTER, G.L. et al. 2000. Changes in endometrial PTEN expression throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 85: 2334-2338.
51. LEVIN, E.R. 2000. Cell localization, physiology, and nongenomic actions of estradiol receptors. J. Appl. Physiol. 91: 1860-1867.
52. HONDA, K. et al. 2000. Phosphatidylinositol 3-kinase mediates neuroprotection by estradiol in cultured cortical neurons. J. Neurosci. Res. 60: 321-327.
53. MCKAY, L.I. & J.A. CIDLOWSKI. 1999. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocrinol. Rev. 20: 435-459.
54. SCHEINMAN, R.I. et al. 1995. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15: 943-953.
55. RAY, P. et al. 1997 Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett. 409: 79-85.
56. KAYISLI, U.A., O. GUZELOGLU-KAYISLI & A. ARICI. 2001. Estrogen receptors ERα and ERβ affect differently the binding of NF-κB to its response element [abstract]. 48th Annual Meeting of the Society for Gynecologic Investigation. J. Soc. Gynecol. Invest. 8: 815.
57. KAYISLI, U.A., O. GUZELOGLU-KAYISLI & A. ARICI. 2001. Activation of NF-κB inhibits the estrogen responsiveness in estrogen receptor-positive cells [abstract]. 48th Annual Meeting of the Society for Gynecologic Investigation. J. Soc. Gynecol. Invest. 8: 38.
58. KAYISLI, U.A. et al. 2001. Regulation of inhibitory I kappa B alpha (IκBα) phosphorylation by estradiol in endometrial cells [abstract]. The 57th Annual Meeting of ASRM. Fertil. Steril. 76: S165
59. KELLY, R.W., A.E. KING & H.O. CRITCHLEY. 2001. Cytokine control in human endometrium. Reproduction 121: 3-19.
60. KING, A.E., H.O. CRITCHLEY & R.W. KELLY. 2001. The NF-kappaB pathway in human endometrium and first trimester decidua. Mol. Hum. Reprod. 7: 175-183.
61. ARICI, A. et al. 1998. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol. Metab. 83: 1201-1205.
62. SELAM, B. et al. 2002. Regulation of fas ligand expression by IL-8 in human endometrium. J. Clin. Endocrinol. Metab. 87: 3921-3927.
63. KOCH, A.E. 1998. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 41: 951-962.
64. TAUB, D.D. et al. 1996. Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukoc. Biol. 59: 81-89.
65. ROSSI, D. & A. ZLOTNIK. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
66. LUSTER, A.D. 1998. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338: 436-445.
67. PREMACK, B.A. & T.J. SCHALL. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2: 1174-1178.
68. GAO, J.I. et al. 1993. Structure and functional expression of the human macrophage inflammatory protein 1a/RANTES receptor. J. Exp. Med. 177: 1421-1427.
69. HOLMES, W.E. et al. Structure and functional expression of a human IL-8 receptor. Science 253: 1278-1280.
70. ARICI, A. et al. Regulation of interleukin-8 gene expression in human endometrial cells in culture. Mol. Cell. Endocrinol. 94: 195-204.
71. JONES, R.L., R.W. KELLY, H.O. CRITCHLEY. 1997. Chemokine and cyclooxygenase-2 expression in human endometrium coincides with the leukocyte accumulation. Hum. Reprod. 12: 1300-1306.
72. HORNUNG, D. et al. 1997. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J. Clin. Endocrinol. Metab. 82: 1621-1628.
73. SELI, E. et al. 2000. Expression of aminopeptidase N in human endometrium and regulation of its activity by estrogen. Fertil. Steril. 75: 1172-1176.
74. MILNE, S.A. et al. 1999. Perivascular interleukin-8 messenger ribonucleic acid expression in human endometrium varies across the menstrual cycle and in early pregnancy decidua. J. Clin. Endocrinol. Metab. 84: 2563-2567.
75. ARICI, A., P.C. MACDONALD & M.L. CASEY. 1996. Progestin regulation of interleukin-8 mRNA levels and protein synthesis in human endometrial stromal cells. J. Steroid Biochem. Mol. Biol. 58: 71-76.
76. KELLY, R.W. et al. 1994. Progesterone control of interleukin-8 production in endometrium and choriodecidual cells underlines the role of the neutrophil in menstruation and parturition. Hum. Reprod. 9: 253-258.
77. ARICI, A. et al. 1999. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol. Reprod. 61: 85-90.